Literature DB >> 16329040

Antioxidant enzymes in renal cell carcinoma.

Y Soini1, J P Kallio, P Hirvikoski, H Helin, P Kellokumpu-Lehtinen, T L J Tammela, M Peltoniemi, P M Martikainen, L V Kinnula.   

Abstract

The aim of the study was to estimate the significance of oxidative/nitrosative damage and expression of antioxidant enzymes in renal cell carcinomas (RCC). For this we investigated immunohistochemically six antioxidant enzymes (AOEs) including MnSOD, ECSOD, thioredoxin, thioredoxin reductase, and gammaglutamyl cysteine synthetase heavy and light chain in 138 RCCs. As an indicator of oxidative/nitrosative damage, sections were stained with an antibody to nitrotyrosine. The extent of apoptosis was evaluated by TUNEL method and proliferation by immunohistochemistry to Ki67. Variable expression of all AOEs could be seen in RCC with expression of MnSOD being strongest. Nitrotyrosine was significantly associated with high grade tumors. MnSOD was associated with tumors of a lower stage. Cases showing ECSOD reactivity had higher and cases expressing thioredoxin lower apoptotic index than other tumors. No association with patient prognosis was observed. According to the results renal cell carcinomas show oxidative/nitrosative damage which, according to nitrotyrosine staining, was higher in high grade tumors. Of AOEs, MnSOD was more abundantly expressed in low stage tumors suggesting that its antioxidant function could play a main role to prevent development of oxidative damage leading to more aggressive tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16329040     DOI: 10.14670/HH-21.157

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  5 in total

Review 1.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

Review 2.  Impact of EcSOD Perturbations in Cancer Progression.

Authors:  Brianne R O'Leary; Rory S Carroll; Garett J Steers; Jennifer Hrabe; Frederick E Domann; Joseph J Cullen
Journal:  Antioxidants (Basel)       Date:  2021-07-29

3.  Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.

Authors:  Sally Järvelä; Kristiina Nordfors; Miia Jansson; Joonas Haapasalo; Pauli Helén; Leo Paljärvi; Hannu Kalimo; Vuokko Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  J Neurooncol       Date:  2008-08-06       Impact factor: 4.130

4.  Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma.

Authors:  Mustafa Aldemir; Ersagun Karaguzel; Emrah Okulu; Ahmet Gudeloglu; Kemal Ener; Asim Ozayar; Ozcan Erel
Journal:  Cent European J Urol       Date:  2015-11-23

5.  The effect of antioxidant status on overall survival in renal cell carcinoma.

Authors:  Ivan Pavlović; Snežana Pejić; Sanja Radojević-Škodrić; Ana Todorović; Vesna Stojiljković; Ljubica Gavrilović; Nataša Popović; Gordana Basta-Jovanović; Zoran Džamić; Snežana B Pajović
Journal:  Arch Med Sci       Date:  2019-07-22       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.